Cocrystal Pharma (COCP) Competitors $1.98 -0.02 (-0.80%) Closing price 01/31/2025 03:58 PM EasternExtended Trading$2.07 +0.10 (+4.96%) As of 01/31/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends COCP vs. DERM, EPRX, ALXO, RANI, ADAG, VTGN, SKYE, EPIX, TLSA, and ASRTShould you be buying Cocrystal Pharma stock or one of its competitors? The main competitors of Cocrystal Pharma include Journey Medical (DERM), Eupraxia Pharmaceuticals (EPRX), ALX Oncology (ALXO), Rani Therapeutics (RANI), Adagene (ADAG), Vistagen Therapeutics (VTGN), Skye Bioscience (SKYE), ESSA Pharma (EPIX), Tiziana Life Sciences (TLSA), and Assertio (ASRT). These companies are all part of the "pharmaceutical products" industry. Cocrystal Pharma vs. Journey Medical Eupraxia Pharmaceuticals ALX Oncology Rani Therapeutics Adagene Vistagen Therapeutics Skye Bioscience ESSA Pharma Tiziana Life Sciences Assertio Journey Medical (NASDAQ:DERM) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Is DERM or COCP more profitable? Cocrystal Pharma has a net margin of 0.00% compared to Journey Medical's net margin of -31.74%. Cocrystal Pharma's return on equity of -94.62% beat Journey Medical's return on equity.Company Net Margins Return on Equity Return on Assets Journey Medical-31.74% -132.10% -26.90% Cocrystal Pharma N/A -94.62%-78.24% Does the media refer more to DERM or COCP? In the previous week, Journey Medical had 1 more articles in the media than Cocrystal Pharma. MarketBeat recorded 4 mentions for Journey Medical and 3 mentions for Cocrystal Pharma. Cocrystal Pharma's average media sentiment score of 0.98 beat Journey Medical's score of 0.69 indicating that Cocrystal Pharma is being referred to more favorably in the news media. Company Overall Sentiment Journey Medical Positive Cocrystal Pharma Positive Which has higher earnings and valuation, DERM or COCP? Journey Medical has higher revenue and earnings than Cocrystal Pharma. Journey Medical is trading at a lower price-to-earnings ratio than Cocrystal Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJourney Medical$79.18M1.20-$3.85M-$0.94-4.84Cocrystal PharmaN/AN/A-$17.98M-$1.85-1.07 Which has more risk & volatility, DERM or COCP? Journey Medical has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Cocrystal Pharma has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Does the MarketBeat Community prefer DERM or COCP? Cocrystal Pharma received 19 more outperform votes than Journey Medical when rated by MarketBeat users. However, 100.00% of users gave Journey Medical an outperform vote while only 77.42% of users gave Cocrystal Pharma an outperform vote. CompanyUnderperformOutperformJourney MedicalOutperform Votes5100.00% Underperform VotesNo VotesCocrystal PharmaOutperform Votes2477.42% Underperform Votes722.58% Do institutionals & insiders hold more shares of DERM or COCP? 7.3% of Journey Medical shares are held by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are held by institutional investors. 13.2% of Journey Medical shares are held by insiders. Comparatively, 25.6% of Cocrystal Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer DERM or COCP? Journey Medical currently has a consensus price target of $9.38, indicating a potential upside of 106.04%. Cocrystal Pharma has a consensus price target of $7.00, indicating a potential upside of 254.25%. Given Cocrystal Pharma's higher possible upside, analysts clearly believe Cocrystal Pharma is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Journey Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Cocrystal Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryJourney Medical beats Cocrystal Pharma on 10 of the 18 factors compared between the two stocks. Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCP vs. The Competition Export to ExcelMetricCocrystal PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.35M$6.87B$5.58B$9.12BDividend YieldN/A2.90%5.31%3.99%P/E Ratio-1.077.6680.0317.24Price / SalesN/A320.221,259.7283.26Price / CashN/A73.5045.9637.70Price / Book0.765.275.124.70Net Income-$17.98M$136.98M$111.40M$224.47M7 Day Performance-5.45%-0.84%2.30%-0.19%1 Month Performance-2.18%-0.02%3.13%0.57%1 Year Performance21.23%7.51%24.60%20.35% Cocrystal Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCPCocrystal Pharma3.6143 of 5 stars$1.98-0.8%$7.00+254.3%+24.3%$20.35MN/A-1.0710Short Interest ↓Gap UpDERMJourney Medical2.5437 of 5 stars$3.98-4.3%$9.38+135.6%N/A$83.14M$79.18M-4.2390Short Interest ↑News CoverageEPRXEupraxia Pharmaceuticals3.6191 of 5 stars$3.02+3.1%$9.00+198.0%N/A$82.39MN/A-4.1929Positive NewsGap DownALXOALX Oncology3.227 of 5 stars$1.56+2.6%$3.05+96.1%-89.9%$82.01MN/A-0.5240Short Interest ↓RANIRani Therapeutics2.7874 of 5 stars$1.43-4.7%$11.71+719.2%-59.8%$81.93MN/A-1.35110Short Interest ↑ADAGAdagene2.6857 of 5 stars$1.85-4.1%$8.00+332.4%-48.1%$81.90M$18.11M0.00260Analyst DowngradeShort Interest ↑Analyst RevisionNews CoverageGap UpVTGNVistagen Therapeutics1.038 of 5 stars$2.88-2.4%N/A-39.5%$80.18M$1.06M-2.3240Short Interest ↑News CoverageSKYESkye Bioscience1.4478 of 5 stars$2.59-6.8%$18.67+620.7%-19.3%$78.58MN/A0.0011News CoveragePositive NewsGap UpEPIXESSA Pharma3.6882 of 5 stars$1.76flat$9.50+439.8%-79.3%$78.13MN/A-2.7550Short Interest ↓News CoverageTLSATiziana Life Sciences1.2699 of 5 stars$0.74-7.1%N/A+29.0%$77.57MN/A0.008Short Interest ↓ASRTAssertio2.8332 of 5 stars$0.81-3.9%$3.25+301.2%-9.1%$77.34M$152.07M-1.1120Short Interest ↓Positive News Related Companies and Tools Related Companies DERM Competitors EPRX Competitors ALXO Competitors RANI Competitors ADAG Competitors VTGN Competitors SKYE Competitors EPIX Competitors TLSA Competitors ASRT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:COCP) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
